alpha-Glucosidases [alfa-glukosidasy]
- Terms
-
alfa-glukosidáza
alfa-glukosidázy
alfa-glukozidázy
kyselá alfa-glukosidáza
kyselá maltasa
kyselá maltáza
maltasy
maltáza
maltázy
neutrální alfa-glukosidasa
neutrální alfa-glukosidáza
neutrální maltáza
α-glukosidáza
-
Acid Maltase
alpha-Glucosidase
Lysosomal alpha-Glucosidase
Maltase
Maltase-Glucoamylase
Maltases
Neutral alpha-Glucosidase
Neutral Maltase
Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II.
- Annotation
- defic/: consider also GLYCOGEN STORAGE DISEASE TYPE II
- DUI
- D000520 MeSH Browser
- CUI
- M0000794
- CAS
- alpha-D-Glucoside glucohydrolases
- Previous indexing
- Glucosidases (1966-1977)
- History note
- 1987(1978)
- Public note
- 1987; see GLUCOSIDASES 1978-1986, for LYSOSOMAL ALPHA-GLUCOSIDASE & ACID MALTASE see GLUCAN 1,4-ALPHA-GLUCOSIDASE 1978-2006
Combination
- antagonists & inhibitors
- Glycoside Hydrolase Inhibitors
Allowable subheadings
- AD
- administration & dosage 7
- AE
- adverse effects 3
- AN
- analysis 3
- BI
- biosynthesis 0
- BL
- blood 2
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 8
- CL
- classification 0
- DF
- deficiency 10
- DE
- drug effects 1
- EC
- economics 1
- GE
- genetics 10
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 4
- ME
- metabolism 11
- PK
- pharmacokinetics 0
- PD
- pharmacology 7
- PH
- physiology 2
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 29
- TO
- toxicity 0
- UL
- ultrastructure 1
- UR
- urine 0